Loading…

Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder

Recepteur d'Origine Nantais (RON) is a distinct receptor tyrosine kinase in the c-met proto-oncogene family. We examined the mutational and expression patterns of RON in eight human uroepithelial cell lines. Biological effects of RON overexpression on cancer cells were investigated in vitro , a...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2005-05, Vol.92 (10), p.1906-1914
Main Authors: Cheng, H-L, Liu, H-S, Lin, Y-J, Chen, H H-W, Hsu, P-Y, Chang, T-Y, Ho, C-L, Tzai, T-S, Chow, N-H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recepteur d'Origine Nantais (RON) is a distinct receptor tyrosine kinase in the c-met proto-oncogene family. We examined the mutational and expression patterns of RON in eight human uroepithelial cell lines. Biological effects of RON overexpression on cancer cells were investigated in vitro , and the prognostic significance of RON and/or c-met protein (MET) expression was analysed in a bladder cancer cohort ( n =183). There was no evidence of mutation in the kinase domain of RON. Overexpression of RON using an inducible Tet-off system induced increased cell proliferation, motility, and antiapoptosis. Immunohistochemical analysis showed that RON was overexpressed in 60 cases (32.8%) of primary tumours, with 14 (23.3%) showing a high level of expression. Recepteur d'Origine Nantais expression was positively associated with histological grading, larger size, nonpapillary contour, and tumour stage (all P
ISSN:0007-0920
1532-1827
DOI:10.1038/sj.bjc.6602593